Zhaoke (Guangzhou) Pharmaceutical Limited   Report issue

Government Phase 1 Phase 3 Phase 4
Founded: Guangzhou China (1951)

Organization Overview

First Clinical Trial
2017
NCT03270735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Zhaoke (Guangzhou) Pharmaceutical Limited | Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited | Zhaoke Pharmaceutical (Hefei) Company Limited

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Dry Eye Syndromes (Phase 3)

Eye Diseases (Phase 3)

Hemoptysis (Phase 4)

Keratoconjunctivitis Sicca (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9